Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Dermatologic 1

Conditions

Neoplasms 6Depression 6Breast Neoplasms 6Multiple Myeloma 5Leukemia 4Brain Neoplasms 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Burkitt Lymphoma 3Vomiting 2Nausea 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Tacrolimus 29fludarabine phosphate 21Methotrexate 21Cyclophosphamide 21Mycophenolic Acid 18Busulfan 15Antilymphocyte Serum 14Whole-Body Irradiation 13Sirolimus 12fludarabine 11Peripheral Blood Stem Cell Transplantation 11Cyclosporine 9thymoglobulin 8Melphalan 8Hematopoietic Stem Cell Transplantation 6Granulocyte Colony-Stimulating Factor 6Filgrastim 6Rituximab 5Pentostatin 5Methylprednisolone 5Thiotepa 4Stem Cell Transplantation 4Radiotherapy 4Cyclosporins 4ruxolitinib 3Vorinostat 3Transplantation 3Flow Cytometry 3Etoposide 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Graft vs Host Disease × Therapeutics × Clear all
NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Scripps Translational Science Institute

Phase NA Terminated
2,117 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT01044745 2023-09-06

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

University of Nebraska

Phase 2 Terminated
20 enrolled 8 charts
DermatologicLymphoidOther hematologic neoplasm

Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡